Business
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021
Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2021.
About this update from Avivagen, Inc.
[{"type":"text","content":"\nAvivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, has announced its unaudited financial results for the second quarter of 2021.\n\n“This quarter has been all about building the foundation for the second half of 2021 and beyond,” says Kym Anthony, Chief Executive Officer, Avivagen Inc. “Already we’ve seen the efforts of the first half of this fiscal year result in record-setting orders. We believe our strategic approach to expanding efforts throughout the Americas positions Avivagen for strong results through both the remainder of the year, and well into the future.”\n\nMilestones achieved in Q2 2021 include:\n\n\nSecured its largest recurring order to date for OxC-betaTM Livestock, an 18-month contract at four tonnes per month for use in Mexico. The 64.5 tonne total order is the largest to date in both size and length of contract, and a direct result of the Meyenberg International Group agreement finalized in Q2.\n\n\nSelected Meyenberg International Group to spearhead expansion efforts in Central and South America.\n\n\nIn conjunction with Mimi’s Rock Corp., announced the launch of Dr. Tobias Beta Blend on Amazon.com – Avivagen’s first product designed for human consumption.\n\n\nAnnounced the closing of its oversubscribed $7.5 million bought deal unit offering.\n\n\nAnnounced the publication of its New Zealand OxC-betaTM Livestock dairy trial for use against sub-clinical mastitis in the New Zealand Veterinary Journal, and its upcoming publication of research highlighting the benefits of OxC-betaTM Livestock for Broiler Poultry in Poultry Science.\n\n\nSince the end of the quarter Avivagen also announced it had:\n\n\nSecured a new customer win in Western Mexico.\n\n\nTerminated its previous exclusive U.S. sales and distribution agreement and initiated discussions with potential partners to ramp up sales efforts in the lucrative region.\n\n\nRecorded its first order from Brazil, received on May 28, 2021.\n\n\nSecured first order with major swine and poultry producer in Thailand following numerous trials.\n\n\nSecond Quarte...